- Home
- World
- UPDATE - Russia's EpiVacCorona Drug Fully Suitable for Re-Vaccination Against COVID-19 - Developer
UPDATE - Russia's EpiVacCorona Drug Fully Suitable For Re-Vaccination Against COVID-19 - Developer
Muhammad Irfan Published April 08, 2021 | 08:20 AM
MOSCOW (UrduPoint News / Sputnik - 08th April, 2021) Russia's EpiVacCorona vaccine is fully suitable for the re-vaccination against COVID-19, the director of the Vector research institute that developed the drug told Sputnik.
"The EpiVacCorona vaccine is fully suitable for the re-vaccination," Rinat Maksyutov said.
According to the institute's director, both doses of the EpiVacCorona vaccine are in fact the same drug.
"EpiVacCorona is a single-component vaccine, which is received by a patient twice with an interval of 21 days," Maksyutov said.
EpiVacCorona is an antigens-based vaccine that was registered by the Russian government on October 13 and is underway with phase 3 clinical trials.
The drug is one of the three vaccines against the coronavirus developed in Russia, along with Sputnik V of Moscow's Gamaleya Institute and CoviVac of the Chumakov research institute.
Related Topics
Recent Stories
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
Putin says plans to visit China in May
More Stories From World
-
Slot 'confident' of Liverpool job as 'negotiations' take place
58 minutes ago -
Google parent Alphabet's Q1 profits beat estimates: company
1 hour ago -
WADA asks 'independent prosecutor' to examine Chinese swimmers case
1 hour ago -
New York court overturns Harvey Weinstein sex crime conviction
1 hour ago -
Bagnaia and Spanish rivals chase victory at Jerez
3 hours ago -
Russian, Ukrainian strikes kill at least 10 in frontline regions
3 hours ago
-
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
3 hours ago -
Tourism must change, mayor says as Venice launches entry fee
3 hours ago -
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leave after 20 years of ..
4 hours ago -
Putin says plans to visit China in May
4 hours ago -
US reinstates open internet rules rescinded under Trump
4 hours ago -
Honda announces US$11 bn EV battery and vehicle plant in Canada
5 hours ago